Story

SpaceX Stock Recovers From Post-Earnings Slump Ahead of Lockup Expiration

ENTHMSVIIDZHZH-TWJAKOHI
Aug 6, 20262 min read
SpaceX Stock Recovers From Post-Earnings Slump Ahead of Lockup Expiration
Text size
Background

Shares of Space Exploration Technologies Corp. (SPCX) gained ground in pre-market trading, rising 1.3% to $109.65 as investors bought into the recent dip ahead of a significant lockup expiration.

The stock's move offers some stability after a sharp sell-off following the company's first-ever quarterly earnings report as a public company earlier this week.

Lockup Expiration in Focus

Investors are positioning for a lockup period ending this Thursday, which will make up to 911.5 million insider-held shares eligible for sale. The event raises the prospect of increased selling pressure on the stock.

However, concerns may be partially mitigated by the staggered nature of the share release. According to the report, senior executives, including the CFO and COO, have their holdings under extended lock-up agreements or pre-arranged trading plans that do not commence until 2027, potentially reducing the immediate supply overhang.

Wall Street Reaffirms Bullish Stance

Following the earnings-driven price drop, several Wall Street analysts reiterated their support for the company. The stock fell after reporting a $541 million net loss and $18.4 billion in capital expenditures, which overshadowed a 92% year-over-year revenue increase to $7.8 billion.

Sample IUX Markets – In-articleAd

In response to the sell-off, analysts moved to defend the stock:

  • JPMorgan raised its price target to $240 from $225.
  • Mizuho reiterated an Outperform rating with a $200 price target.
  • RBC Capital and Deutsche Bank both maintained Buy ratings with price targets of $225.

The average 12-month analyst price target stands at approximately $223, implying significant potential upside from its current price.

Market Context

The stock's recovery comes after a volatile period since its June IPO at $135 per share. Its 52-week range of $104.83 to $225.64 highlights the significant repricing that has occurred. Today's gains suggest that the combination of analyst support and a more nuanced view of the lockup expiration is allowing the stock to find a footing, even as the market continues to debate its long-term spending trajectory.

Read next

More on Stocks
Back to latest news

LATEST